ArticlePloS one2012

Protection against high-dose highly pathogenic mucosal SIV challenge at very low serum neutralizing titers of the antibody-like molecule CD4-IgG2.

Pascal Poignard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.